SAN FRANCISCO — A pair of pro se litigants surrendered a patent that they allegedly snatched from law firm files, ending their splashy trial with famed litigator David Boies.
Two days into a San Jose jury trial, inventor Richard Fuisz and his son Joseph settled their suit with Boies, Schiller & Flexner client Theranos Inc., a high-profile medical testing startup. As part of the deal, the parties agreed that the Fuiszes’ patent for bodily fluid analysis will be declared invalid. The Fuiszes were accused of filing the patent application with confidential Theranos documents handed to them by a partner at McDermott, Will & Emery—an allegation the firm and the partner deny.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
